PK5 Intrinsic Valuation and Fundamental Analysis - Basilea Pharmaceutica AG

B	Basilea Pharmaceutica AG XBER:PK5	CH
	Minehub Technologies Inc F:2RS	CA
F	Fayenceri Sarreguemin Digoin Vitry Franc SA PAR:FAYE	FR
	Iron Road Ltd ASX:IRD	AU
	O P Chains Ltd BSE:539116	IN
M	Mystic Holdings Inc OTC:MSTH	US
	Camerit AG F:RTML	DE
	Valiant Eagle Inc OTC:PSRU	US
W	Winix Inc KOSDAQ:044340	KR
G	Gielda Praw Majatkowych Vindexus SA WSE:VIN	PL
	Integrated Wellness Acquisition Corp OTC:WELNF	US
	Aedes SIIQ SpA MIL:AED	IT
	Azincourt Energy Corp F:A0U0	CA
L	Life Insurance Company of Alabama OTC:LINS	US
P	Petroneft Resources PLC XBER:P8ET	IE

Intrinsic Value

PK5 price has not been updated for more than 3 years. This may indicate that the stock has been delisted.

The intrinsic value for Basilea Pharmaceutica AG (PK5) under the Base Case is hidden EUR. Compared with the current market price of 32.1 EUR, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

DCF valuation

Locked

Wall St target

€60.63

Do our valuations actually work? See backtest results .

PK5 Intrinsic Value

Unlock

Valuation context is not available yet

There is not enough comparable price and intrinsic value history for PK5.

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Current Price €32.1

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Basilea Pharmaceutica AG.

Explain Valuation